All
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
OxyContin, Purdue Pharma
Purdue Pharma and owners to pay $7.4 billion in settlement to lawsuits over the toll of OxyContin
The Sackler family agreed to give up ownership of the company that manufactures the powerful opioid. A previous deal was rejected by the Supreme Court.
Purdue Pharma Agrees To $7 Billion Settlement Over OxyContin's Role In Opioid Crisis
Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role in the opioid epidemic. The deal follows the U.S. Supreme Court’s rejection of a $6 billion agreement last year.
AG: Pa. part of $7.4B OxyContin settlement proposal with Purdue Pharma, Sackler family
Pennsylvania stands to receive up to $212 million paid out by the family and company behind the nationwide saturation of OxyContin as part of the latest legal settlement stemming from
3d
on MSN
OxyContin makers to pay up to $7.4B in new deal
Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a ...
3d
PA expected to receive over $200 million in settlement with OxyContin makers, if approved
Pennsylvania expects to receive $212 million over 15 years as part of a multi-state settlement with the Sackler family, who ...
St George News
2d
Utah reaches tentative agreement to settle opioid liability against the Sackler family behind OxyContin
Several states have announced an agreement in principle to settle lawsuits across the country over opioid harms and abate the ...
2d
Bankrupt Purdue buys time to advance $7.4 billion opioid deal
Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Related topics
Purdue Pharma
Raymond Sackler
Feedback